Premier Health Reports 2025 Third Quarter Results

Premier Health Reports 2025 Third Quarter Results

Premier Health of America Inc. (TSXV: PHA,OTC:PRHAF ) (the " Company "), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial Statements and MD&A for its third quarter ended on June 30, 2025.

Highlights
(in thousands of Canadian dollars) June 30,
2025

(3 months
) June 30,
2024
(3 months
) June 30 ,
2025

(9 months
) June 30,
2024
(9 months
)
Revenues 21,910 41,482 81,179 124,732
Gross margin (1) 3,489 6,380 13,155 22,569
Gross margin as a % of revenues 15.9 % 15.4 % 16.2 % 18.1 %
Adjusted EBITDA (1) 22 367 963 5,565
Net Loss (3,531 ) (8,452 ) (8,943 ) (10,214 )

(1) See the Company's MD&A for details on these non-GAAP measures.

Summary

  • Adjusted EBITDA for the quarter was $22K ($367K for the same period in 2024), mainly driven by a decline in volume in Quebec and British Columbia.
  • Net Loss for the quarter was $3.5M (loss of $8.4M for the same period in 2024), the result of lower Adjusted EBITDA, partly offset by favorable fair value adjustments and lower income tax.

The effects of the implementation of Quebec's Bill 10 continued impacting the Per Diem segment during this quarter. As a reminder, Bill 10 imposes capped rates and a series of restrictions for using independent labor in Quebec. The Per Diem business now represents around 4% of revenues.

The travel nurse and northern communities' services are generally performing well except in BC where we are experiencing a volume reduction. This can be attributed to a service acquisition centralization effort by the health authorities, that we expect will eventually favour the best service providers. In addition, the initial rollout of the new contract caused certain delays in bookings as the new rules came into effect. CHCA also experienced a decline in hours and revenue in May and June, due to contract cancellations stemming from wildfire-related evacuations in various affected regions of Ontario.

The Company has continued to work on the reorganization of its Quebec operations. During Q3, it continued to reduce the workforce in that province as well as in the corporate structure. Cost savings are on track with the amounts disclosed in Q4 of 2024 and should carry on in the coming quarters as the various initiatives are fully deployed. Cost structure at our BC subsidiary is also being adapted to address to the market conditions in that province.

"Our cost reduction plan is still progressing, and additional efforts were deployed in the current quarter. The Per Diem segment is largely nonexistent, and our focus will fully shift to Travel Nurses. The Home Care sector presents interesting opportunities, and we are evaluating our capacity to gradually enter this market as well as calls for tenders in Quebec and Ontario. In the short term, we remain committed to cost reduction, debt management, operational efficiency, and pursuing organic growth opportunities," said Guy Daoust, Interim CEO of Premier Health.

More information can be found in the Company's quarterly financial statements and MD&A as available on sedarplus.ca.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, companies, and individuals. Premier Health uses its proprietary LiPHe ® platform to lead the digital transformation of the healthcare services sector, providing patients with faster, more affordable, and more accessible care.

Non-GAAP Measures

Earnings before interest, taxes, depreciation, and amortization ("EBITDA"), is calculated as the net profit (loss), before non-recurring items excluding acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization, and depreciation), change in fair values, interest expense, and income tax expense (recovery). Adjusted EBITDA excludes Share-based compensation and unusual items, as determined from time to time. Gross margin is either used as a number or a percentage. As a number, it means Revenues minus Direct Costs. When used as a percentage, it means the ratio of Revenues minus Direct Costs to Revenues. More detail can be found in PHA's Management Discussion and Analysis.

For Further Information Please Contact:

Mr. Jean-Robert Pronovost
Vice President Corporate Development
Premier Health of America Inc.
jrpronovost@premierhealth.ca / 1 800 231 9916
Mr. Guy Daoust
Interim Chief Executive Officer
Premier Health of America Inc.
gdaoust@premierhealth.ca / 1 800 231 9916


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This press release contains forward-looking information within the meaning of applicable securities legislation which reflects the current plans and expectations of the Company with respect to future events and financial performance. All statements other than statements of historical or current facts may be forward-looking information. Forward-looking information includes statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as ‘believes', ‘continues', ‘expects', ‘projects', ‘anticipates', ‘plans', ‘estimates', ‘seeks', ‘intends', ‘targets', ‘forecasts', or negative or grammatical versions thereof and other similar expressions, or future or conditional verbs such as ‘may', ‘will', ‘should', ‘would' and ‘could'. Forward-looking information in this press release includes, but is not limited to, statements with respect to the execution of the Company's growth strategy. Forward-looking information is based on management's plans, estimates, projections, beliefs and opinions as at the date of this release, and the assumptions related to those plans, estimates, projections, beliefs and opinions may change; therefore, they are presented for the purpose of assisting the Company's security holders in understanding management's views at such time regarding those future outcomes and may not be appropriate for other purposes. Although the forward-looking information contained in this release is based on assumptions which the Company believes are reasonable, there can be no assurance that actual results will be consistent with such forward-looking information. The forward-looking information in this release relate only to events or information as of the date on which the statements are made and, except as specifically required by applicable securities laws, the Company undertakes no obligation to update or revise publicly any forward-looking information, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. There can be no assurance that the forward-looking information will prove to be accurate. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Company with Canadian securities regulatory authorities available at www.sedarplus.ca


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PHA:CA
The Conversation (0)
Premier Health of America

Premier Health of America


Keep reading...Show less

Modernizing Healthcare Staffing with Automated, On-Demand Services

Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announced today that the TSX Venture Exchange (" TSXV ") has accepted the Corporation's application for its normal course issuer bid (the " NCIB ") for a portion of its outstanding common shares (" Common Shares ") as appropriate opportunities arise from time to time. The Corporation's NCIB will be made in accordance with the requirements of the TSXV and applicable securities laws.

Pursuant to the NCIB, Premier Health may repurchase up to a maximum of 1,428,571 Common Shares representing approximately a value of $500,000 at the current market price and 7% of its public float, where the aggregate public float as at November 14, 2022, was 19,664,860 Common Shares. Purchases under the NCIB may be made through the facilities of the TSXV, based on the prevailing market price at the time of acquisition. The NCIB will be funded using existing cash resources and any Common Shares purchased under the NCIB will be cancelled.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Announces CFO Transition

Premier Health Announces CFO Transition

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, today announced that it is proceeding with a transition of the CFO functions and appoints Simon Belval as Interim Chief Financial Officer, effective immediately.

Simon Belval is a seasoned professional that has demonstrated strong abilities and leadership in finance and accounting functions including IFRS reporting, tax planning, financing, and risk management in different environments. He has held several leadership roles in the technology and fintech sectors and has developed over the years an expertise in managing strategic initiatives and special situations. He started his career as an external auditor and later acted as senior financial analyst for major organizations in Eastern Canada. Simon is a member of the Ordre des comptables professionnels agrées du Québec (CPA) and a Chartered Financial Analyst (CFA).

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Reports FY2022 Third Quarter Results

Premier Health Reports FY2022 Third Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its third quarter ended June 30, 2022.

Summary

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Reports FY2022 Second Quarter Results

Premier Health Reports FY2022 Second Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022.

Summary

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health of America

Premier Health Announces the Appointment of Giovanni Garay as Ontario General Manager

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announces the appointment of Giovanni Garay as Ontario General Manager, effective immediately.

"We are very excited to have Giovanni join Premier Health. His hiring follows our recent acquisition in Ontario, and he will be an important member of the Corporation's senior leadership team," said Martin Legault, Chief Executive Officer. "Giovanni's experience with large organisations will benefit Premier Health as we continue to expand our footprint in the province." he added.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.

This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and prevention of diseases and physical conditions, and it continues to develop rapidly.

Examples of medical devices include neurostimulation devices, surgical implants, ultrasound imaging devices and robotic medical technology, along with insulin pumps and insulin pens for diabetes. Just as pharmaceutical companies seek to serve unmet needs, medical device companies do the same via innovative technologies.

Keep reading...Show less
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Latest Press Releases

Related News

×